journal article·2021-02-26

Gold Nanoclusters Perform Enzyme-like Photocatalysis for Prodrug Activation

Rong Liu, Dajiao Cheng, Quan Zhou, Fushuang Niu, Ke Hu

ACS Applied Nano Materials· Volume 4· Issue 2
Publisher page

Abstract

Many synthetic nanomaterials known as nanozymes can catalyze biologically relevant molecular transformations just as natural enzyme does. “Photonanozyme” utilizes light as a spatial and temporal control for the regulation of nanozyme activities. Here we report a glutathione-modified gold nanocluster as a photonanozyme that catalyzes the reduction of nitrobenzene under light. Aniline was found as the sole photoreductive product. The photocatalytic reactions at variable light fluences were found to follow the classical Michaelis–Menten enzyme kinetics from which kinetic rate constants were quantified. Intracellular reduction of a nitro-group-containing fluorescent probe demonstrates the viability of gold nanoclusters as biocompatible photonanozymes performing catalysis in a mammalian cell environment. This study reinvents gold nanoclusters as photonanozymes that mimic naturally occurring nitroreductase for potential prodrug activation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Advanced Nanomaterials in Catalysis · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Fudan University, 220 Handan Road, Shanghai 200433, P. R. China

Funding

National Natural Science Foundation of China

References (27)

Show source-provided references
1. 10.1021/jacs.5b0409710.1021/jacs.5b04097 ↗
2. 10.1021/ja401360a10.1021/ja401360a ↗
3. 10.1039/D0SC04329J10.1039/D0SC04329J ↗
4. 10.1021/jacs.0c0162210.1021/jacs.0c01622 ↗
5. 10.1021/jacs.9b0083710.1021/jacs.9b00837 ↗
6. 10.1021/acs.chemrev.8b0049310.1021/acs.chemrev.8b00493 ↗
7. 10.1039/C9NR10822J10.1039/C9NR10822J ↗
8. 10.1002/anie.20180028810.1002/anie.201800288 ↗
9. 10.1021/acscatal.9b0286310.1021/acscatal.9b02863 ↗
10. 10.1021/ja505361n10.1021/ja505361n ↗
11. 10.1021/acs.jpclett.7b0159710.1021/acs.jpclett.7b01597 ↗
12. 10.1021/acsenergylett.8b0007010.1021/acsenergylett.8b00070 ↗
13. 10.1042/BJ2015065010.1042/BJ20150650 ↗
14. 10.1021/ja306199p10.1021/ja306199p ↗
15. 10.1021/jp410856h10.1021/jp410856h ↗
16. 10.1021/am100107k10.1021/am100107k ↗
17. 10.1021/acscatal.8b0400510.1021/acscatal.8b04005 ↗
18. 10.1021/jacs.5b1135310.1021/jacs.5b11353 ↗
19. 10.1021/jacs.5b0754010.1021/jacs.5b07540 ↗
20. 10.1021/jp101125j10.1021/jp101125j ↗
21. 10.1021/acscatal.0c0072510.1021/acscatal.0c00725 ↗
22. 10.1021/ja00851a03010.1021/ja00851a030 ↗
23. 10.1016/j.jhazmat.2007.02.02110.1016/j.jhazmat.2007.02.021 ↗
24. 10.1016/S0167-4838(98)00151-410.1016/S0167-4838(98)00151-4 ↗
25. 10.1021/ja501736510.1021/ja5017365 ↗
26. 10.1016/j.ccr.2020.21346010.1016/j.ccr.2020.213460 ↗
27. Chung-Faye G. · Clin. Cancer Res. · 2001 · 7 · 2662